Zymeworks Inc (ZYME) Stock Price Today & Analysis

ZYME
ZYME company logo
Loading...
Chart by TradingView

Valuation

Market cap$1.77B
Price-to-sales ratio13.15
Price-to-book value5.53
Price-earnings ratio-27.90
Return on Equity-19.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A

Earnings Per Share

Earnings Per Share$-0.85

Income Statement

Average volume913,692
EBITDA$-43.27M
1 year high (52w)$28.49
1 year low (52w)$9.03

Dividend

Dividend yield0.00%

Solvency

Debt-to-equity ratioN/A

About Zymeworks Inc

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

FAQ

You can easily purchase Zymeworks Inc (ZYME) shares through the Gotrade app. Simply download the app, set up your account, fund it, and then search for the 'ZYME' ticker to begin your investment journey.

At Gotrade, you can kickstart your investment in Zymeworks Inc with as little as $1.

Absolutely. Brokerage services on Gotrade Indonesia are provided by PT Valbury Asia Futures, a licensed futures and commodities broker registered with and supervised by the Indonesian Financial Services Authority (OJK).

Yes. Gotrade provides access to U.S. stocks from Indonesia through fully backed shares. This is facilitated through a cross-border order routing scheme for foreign stock derivative contracts (PALN), in accordance with regulations from Bappebti (the Commodity Futures Trading Regulatory Agency).
When you trade, you enter into a contract with PT Valbury Asia Futures (Valbury), a Bappebti-registered broker in Indonesia. Valbury, in turn, fully backs its contracts 1-for-1 with Alpaca Securities LLC, a FINRA-licensed broker-dealer in the United States. For every share (or fraction thereof) you hold on Gotrade, a corresponding share is held by Valbury in a separate, segregated brokerage account at Alpaca Securities LLC.

AppLogo

Buy saham ZYME
di Gotrade

AppLogo

Gotrade